These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9607735)

  • 41. Detecting bacterial contamination in platelet products.
    Palavecino EL; Yomtovian RA; Jacobs MR
    Clin Lab; 2006; 52(9-10):443-56. PubMed ID: 17078471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Indications for transfusions of labile blood products].
    Wautier JL
    Transfus Clin Biol; 2005 Feb; 12(1):56-8. PubMed ID: 15814294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
    Levi M; Friederich PW; Middleton S; de Groot PG; Wu YP; Harris R; Biemond BJ; Heijnen HF; Levin J; ten Cate JW
    Nat Med; 1999 Jan; 5(1):107-11. PubMed ID: 9883848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Refractoriness to platelet transfusion].
    Tsurumi H; Hara T; Moriwaki H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):332-4. PubMed ID: 9833505
    [No Abstract]   [Full Text] [Related]  

  • 46. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
    Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe Thrombocytopenia in the NICU.
    Baer VL; Lambert DK; Henry E; Christensen RD
    Pediatrics; 2009 Dec; 124(6):e1095-100. PubMed ID: 19917581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consensus conference on platelet transfusion: 27 and 28 November 1997: final statement.
    Contreras M
    Leukemia; 1998 Aug; 12(8):1330-1. PubMed ID: 9697895
    [No Abstract]   [Full Text] [Related]  

  • 49. Inadequacies in the postnatal management of fetomaternal alloimmune thrombocytopenia (FMAIT).
    Murphy MF; Verjee S; Greaves M
    Br J Haematol; 1999 Apr; 105(1):123-6. PubMed ID: 10233374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet transfusion therapy. National Institutes of Health Consensus Conference.
    Transfus Med Rev; 1987 Dec; 1(3):195-200. PubMed ID: 2980279
    [No Abstract]   [Full Text] [Related]  

  • 51. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
    Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR
    In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
    Cameron B; Rock G; Olberg B; Neurath D
    Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Platelet transfusion: products, indications, dose, threshold and efficacy].
    Andreu G; Vasse J; Tardivel R; Semana G
    Transfus Clin Biol; 2009 May; 16(2):118-33. PubMed ID: 19443257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A clinical audit on the practice of platelet transfusions at a tertiary paediatric referral centre.
    Jamal R; Hoe TS; Ong LC; Afifah I; Khuzaiah R; Doraisamy G
    Malays J Pathol; 1998 Jun; 20(1):35-40. PubMed ID: 10879262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing platelet transfusions in chronically thrombocytopenic patients.
    Slichter SJ
    Semin Hematol; 1998 Jul; 35(3):269-78. PubMed ID: 9685173
    [No Abstract]   [Full Text] [Related]  

  • 57. [Recommendations for platelet transfusion by the Joint Thrombocyte Working Party of the German Societies of Transfusion Medicine and Immunohaematology (DGTI), Thrombosis and Haemostasis Research (GTH), and Haematology and Oncology (DGHO)].
    Greinacher A; Kiefel V; Klüter H; Kroll H; Pötzsch B; Riess H; ; ;
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2675-9. PubMed ID: 17109279
    [No Abstract]   [Full Text] [Related]  

  • 58. An update on platelet transfusion in hematooncology supportive care.
    Buhrkuhl DC
    Transfusion; 2010 Oct; 50(10):2266-76. PubMed ID: 20492606
    [No Abstract]   [Full Text] [Related]  

  • 59. Final statement from the consensus conference on platelet transfusion.
    Contreras M
    Transfusion; 1998 Aug; 38(8):796-7. PubMed ID: 9709789
    [No Abstract]   [Full Text] [Related]  

  • 60. Consensus conference on platelet transfusion. Final statement.
    Contreras M
    Transfus Sci; 1998 Jun; 19(2):111-4. PubMed ID: 10187034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.